Authors


Melinda Magyari, MD

Latest:

Unpacking the Controversy of Hormone Therapy in Multiple Sclerosis: Melinda Magyari, MD

The neurologist in the Danish Multiple Sclerosis Center at Copenhagen University Hospital discussed the debate surrounding the use of hormone therapy in multiple sclerosis treatment, highlighting the need for more clinical evidence to support its use. [WATCH TIME: 5 minutes]


Jill Dehlin, RN

Latest:

Treating Patients With Migraine

What physicians in the community need to know about treating patients with migraine in community settings, and resources that can help locate certified headache specialists or other migraine specialists for referral.


Evelyn Sbar, MD

Latest:

Building Your Acute Migraine Toolbox

Plagued by a long history of under- and inadequate treatment, clinicians have more options than ever to craft a personalized, effective plan for their patients.


Abhishek Lenka, MD, PhD

Latest:

Managing Nonmotor Symptoms: Psychosis in Parkinson Disease

Psychosis is estimated to affect more than half of patients with Parkinson disease, and there is a growing need for improved management and therapeutic development.


Adam Naj, PhD

Latest:

Collaborative Efforts for Health Equity in Alzheimer Disease Genetic Research: Adam Naj, PhD

The genetic epidemiologist at the University of Pennsylvania discussed a recent study that highlighted the importance of diverse samples in genetic research for Alzheimer disease in helping to uncover hidden genetic risk factors. [WATCH TIME: 2 minutes]


Steven Vernino, MD, PhD

Latest:

AUPN Leadership Minute Episode 5: Planning a Faculty Retreat

Episode 5 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Steven Vernino, MD, PhD, of UT Southwestern Medical Center. [WATCH TIME: 4 minutes]


Jinsy A. Andrews, MD, MSc

Latest:

AUPN Leading Edge Episode 6: Transitioning From Academics to Industry and Vice Versa

AUPN Leading Edge Episode 6 features John D. England, MD, FAAN, and Jinsy Andrews, MD, MSc, who discuss the experiences, opportunities, and challenges while transitioning between academia and industry. [LISTEN TIME: 33 minutes]


Bijan Nejadnik, MD

Latest:

Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

The chief medical officer at SanBio discussed how the investigational agent SB623 is being studied in TBI and stroke, with future planned studies in Alzheimer disease.


Jose Soria, MD

Latest:

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.


Aristide Merola, MD, PhD

Latest:

Advanced Parkinson Disease: Looking Ahead

Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.


Masahito Kawabori, MD, PhD

Latest:

Stem Cell Therapy for TBI: Masahito Kawabori, MD, PhD

The associate professor at Hokkaido University and investigator of STEMTRA also discussed other efforts in stroke, Alzheimer disease, and Parkinson disease.


Ilya Kister, MD

Latest:

Greatest Recent Advancements in MS, Looking Toward the Future: Ilya Kister, MD

The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the most notable strides within the multiple sclerosis field in the past year. [WATCH TIME: 3 minutes]


Katie Abouzahr, MD

Latest:

Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD

The vice president, Autoantibody Portfolio and Maternal Fetal Immunology Disease Area Leader, Johnson & Johnson, provided perspective on the unique molecular structure of nipocalimab seen across nonclinical and clinical studies. [WATCH TIME: 3 minutes]


Gunter Hoglinger, MD

Latest:

Mechanistic Approach Behind AMX0035 in Progressive Supranuclear Palsy: Gunter Hoglinger, MD

The professor of neurology and translational neuroscientist at Ludwig-Maximillian’s University Munich detailed the logic behind the ORION study, a new trial assessing AMX0035, an approved therapy for ALS, in patients with progressive supranuclear palsy. [WATCH TIME: 4 minutes]


Lianrui Zuo, MSE

Latest:

Enhancing Consistency in Neuroimaging With AI and Image Harmonization: Lianrui Zuo, MSE

The PhD student in the department of electrical and computer engineering at Johns Hopkins University discussed the use of artificial intelligence and image harmonization techniques to address the challenges caused by multisite effects in neuroimaging. [WATCH TIME: 4 minutes]


Jay Alberts, PhD

Latest:

Challenges With Assessing Stages of Parkinson Disease and the Lack of Standardized Biomarkers: Jay Alberts, PhD

The Edward F. and Barbara A. Bell Endowed Chair at Cleveland Clinic discussed the complexities with identifying viable biomarkers for Parkinson disease, as well as interventions geared toward specific regions of the brain. [WATCH TIME: 4 minutes]


Jan Brandes, MD, MS

Latest:

Attracting More Women to Neurology: Jan Brandes, MD, MS

The assistant clinical professor at Vanderbilt University School of Medicine discussed ways of incorporating and encouraging women physicians to enter the neurology specialty. [WATCH TIME: 4 minutes]


Julienne Verdi

Latest:

Successes and Advances in Migraine Care Through Headache on the Hill: Julienne Verdi

The executive director of the Alliance for Headache Disorders Advocacy discussed some of the successes from recent Headache on the Hills, and the expansion in centers of excellence for veterans with migraine. [WATCH TIME: 6 minutes]


Susana Vacas, MD, PhD

Latest:

Improving Surgery Communication, Risk Factor Assessment for Older Adults: Susana Vacas, MD, PhD

Following the publication of a recent article outlining the association of the use of anesthesia during surgery and cognitive decline in older adults, the assistant professor of anesthesiology at the David Geffen School of Medicine, UCLA, spoke on the need to assess risk factors. [WATCH TIME: 5 minutes]


Henri Ford, MD, MHA

Latest:

Driving Innovation in Aging and Neurodegenerative Research: Henri Ford, MD, MHA

The dean and chief academic officer at the University of Miami Miller School of Medicine discussed the university’s investment in computational biology to advance aging and neuroscience research. [WATCH TIME: 5 minutes]


Shiv Saidha, MBBCh

Latest:

Reevaluating Neuroprotective Multiple Sclerosis Trial Designs Using the Visual System: Shiv Saidha, MBBCh

The professor of neurology at Johns Hopkins Medicine discussed the trial design of the phase 4 RENEW study assessing the long-term safety profile of mitoxantrone in multiple sclerosis. [WATCH TIME: 9 minutes]


Angela Genge, MD, FRCPC, eMBA

Latest:

Restoring Protein Levels With QRL-201 Has Potential to Stabilize Disease Progression in ALS: Angela Genge, MD, FRCPC, eMBA

The chief medical officer of QurAlis talked about the potential of QRL-201 in patients with ALS from her talk presented at the 2023 MDA conference. [WATCH TIME: 4 minutes]


Saud A. Sadiq, MD, FAAN

Latest:

Intrathecal Mesenchymal Stem Cells as a Potential Treatment for Progressive Multiple Sclerosis: Saud A. Sadiq, MD, FAAN

The director and chief research scientist at Tisch MS Research Center of New York talked about a phase 2 data study on stem cell treatment for multiple sclerosis that was presented at the 2023 AAN Annual Meeting. [WATCH TIME: 7 minutes]


Chris Berka

Latest:

NeuroVoices: Chris Berka on Advancing Early Detection of Neurodegenerative Diseases with EEG Biomarkers

The CEO and cofounder at Advanced Brain Monitoring talked about a study presented at AAIC 2024 that explored the use of EEG biomarkers to differentiate between Alzheimer disease and frontotemporal dementia.


James Beck, PhD

Latest:

Using a Blood Collection Device to Advance Genetic Research in Parkinson Disease: James Beck, PhD & Ben Casavant, PhD

The chief scientific officer of the Parkinson’s Foundation and chief executive officer of Tasso discussed their company partnership to expand and accelerate genetic research in Parkinson Disease. [WATCH TIME: 6 minutes]


Fracesco Saccà, MD, PhD

Latest:

Therapeutic Potential of Dimethyl Fumarate to Treat Friedreich Ataxia: Francesco Saccà, MD, PhD

The associate professor of neurology at the University of Naples provided context on the mechanism of action for dimethyl fumarate and why there’s belief it can benefit patients with Friedreich ataxia. [WATCH TIME: 4 minutes]


Pavel Klein, MD

Latest:

A Paradigm Shift in Preventing Drug-Resistant Epilepsy: Pavel Klein, MD

The director of the Mid-Atlantic Epilepsy & Sleep Center and adjunct associate professor of neurology at George Washington University discussed the advancements in epilepsy research, especially for drug-resistant epilepsy, to be presented at AES 2023. [WATCH TIME: 4 minutes]


William L. Conte, MD, MS

Latest:

Importance of Diversity and Inclusion in MS Care for the LGBTQ+ Patient Population: William L. Conte, MD, MS

The head of the MS Center at Methodist Hospitals and assistant professor of neurology at Indiana University talked about the significance of diversity and the health disparities faced by patients with multiple sclerosis in the LGBTQ+ community. [WATCH TIME: 3 minutes]


Suma Shah, MD

Latest:

The Ever-Expanding Multiple Sclerosis Therapeutics

Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.


Heidi Crayton, MD

Latest:

Conversations With Patients About Mild/Moderate Multiple Sclerosis

The expert panel examines early multiple sclerosis (MS) and patients with mild MS even in later stages of the disease, emphasizing crucial information to convey to patients throughout their journey; faculty also explore cases where disease-modifying therapies (DMTs) may not be utilized.

© 2024 MJH Life Sciences

All rights reserved.